On track to meet margin & growth guidance for FY25′, says Himanshu Baid, MD of Poly Medicure. Tells Prashant Nair, Surabhi Upadhyay & Nigel D’Souza that they see 50% growth in renal biz in FY25. Adds higher tariffs in the US may not impact exports from India